13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Latham & Watkins Advises on Travere Therapeutics’ Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Travere Therapeutics, Inc. (Nasdaq: TVTX) has announced the pricing of an underwritten public offering of 8,275,000 shares of its common…
Latham & Watkins Advises on Option Care Health’s Secondary Offering of Common Stock and Common Stock Repurchase
Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, has announced…
Latham & Watkins Advises on Option Care Health’s Secondary Offering of Common Stock and Common Stock Repurchase
Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, has announced…
Latham Advises Tencent on Its €36 Million Subscription of New Shares Issued by DON’T NOD
Latham & Watkins has advised Tencent, a world-leading internet and technology company, on its subscription of €36 million of new…
Latham Advises Tencent on Its €36 Million Subscription of New Shares Issued by DON’T NOD
Latham & Watkins has advised Tencent, a world-leading internet and technology company, on its subscription of €36 million of new…
Latham & Watkins Advises HUB on de-SPAC Business Combination with Mount Rainier Acquisition Corp.
Latham & Watkins advised HUB Cyber Security Ltd. (HUB), a developer of Confidential Computing cybersecurity solutions and services, on the…
